Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy-Reference-Cited by-同舟云学术

Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy

Published:2020-01-28 Issue:6 Volume:111 Page:897-902
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Ureshino Hiroshi^ORCID,Koarada Shuichi,Kamachi Kazuharu,Yoshimura Mariko,Yokoo Masako,Kubota Yasushi,Ando Toshihiko,Ichinohe Tatsuo,Morio Tomohiro,Kimura Shinya

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-020-02834-9.pdf

Reference26 articles.

1. Gutierrez-Arcelus M, Rich SS, Raychaudhuri S. Autoimmune diseases—connecting risk alleles with molecular traits of the immune system. Nat Rev Genet. 2016;17:160–74.

2. Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27:109–18.

3. Friedline RH, Brown DS, Nguyen H, Kornfeld H, Lee J, Zhang Y, et al. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J Exp Med. 2009;206:421–34.

4. Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523–32.

5. Bacchetta R, Notarangelo LD. Immunodeficiency with autoimmunity: beyond the paradox. Front Immunol. 2013;4:3389.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression in Patients With Primary Immunodeficiency—Walking the Line;The Journal of Allergy and Clinical Immunology: In Practice;2022-12

2. Inborn errors of immunity and immunodeficiencies: Antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions;European Journal of Immunology;2022-04-30

3. Abatacept for treatment-refractory pediatric CTLA4-haploinsufficiency;Clinical Immunology;2021-08

4. Microarrays and NGS for Drug Discovery;Drug Design - Novel Advances in the Omics Field and Applications;2021-06-16

5. Gastric cancer, inflammatory bowel disease and polyautoimmunity in a 17-year-old boy: CTLA-4 deficiency successfully treated with Abatacept;European Journal of Gastroenterology & Hepatology;2021-05-21